The Natural Chemotherapeutics Research Institute is one of the beneficiaries of an investment by The Presidential Scientific Initiative on Epidemics (PRESIDE), into research studies to evaluate therapeutics that have potential to contribute to the fight of the SARS-COV-2 (COVID-19) pandemic.

Attachments

Your email address will not be published. Required fields are marked *

*

COVID-19 - Hope is here by NCRI

A CLINICAL EVALUATION OF EFFICACY, SAFETY IMMUNOGENICITY AND RELIABILITY OF UBV-01N- A NOVAL NATURAL PRODUCT- IN ADULT PATIENTS INFECTED WITH SARS-COV-2 (COVID-19), IN UGANDA